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FORMATION OF DIHYDROXYPHENYLALANINE FROM TYROSINE
BY COUPLED OXIDATION WITH ASCORBIC ACID*
C. G. VAN ARMANt, M.S., AND K. K. JONES, PH.D.
Dihydroxyphenylalanine (dopa) has been thought to be intermediate in the
formation of many important biological compounds, such as the melanin pigments
and various pressor agents. This compound has been obtained from plants and
from lower forms of animal life, but its isolation from normal mammalian tissues
is open to question. Its presence in mammalian tissue has been inferred from
several facts. There is, first of all, an enzyme in the pigment cells of the skin
which is a specific oxidase for 1-dopa (1). This eiizyme has been shown in
melanotic tumors of the mouse (2, 3). Small amounts of dopa are formed by
irradiation of tyrosine with ultraviolet light (4, 5, 6). It is well known, also, that
dopa quickly turns into melanin-like pigments upon oxidation; Raper (7) has
proposed a mechanism for the reaction. Some workers believe that pigment in
the skin is formed in this manner. Normal human urine contains hydroxytyra-
mine which probably arises from dopa by enzymic decarboxylation. A specific
decarboxylase has been demonstrated in kidney tissue of several mammalian
species (8, 9, 10). The presence of this decarboxylase implies the presence of
dopa in the tissues.
There is good evidence (11) that the parent substance of epinephrine is phenyl-
alanine which could become transformed to tyrosine first, and then to dopa.
Bloch and Löffler (12) propose that the bronzing of the skin in Addison's disease
may be due to the fact that this compound can no longer be converted into epi-
nephrine and stored in the adrenal glands but becomes converted to pigments
instead. Large amounts of 1-dopa have been found in the urine of a patient
suffering from the rare disease, tyrosinosis (13). Thus far, however, its presence
in normal tissue is not proved.
Nevertheless, further indirect evidence may be obtained by finding whether
or not dopa may be formed in vitro by some chemical system known to exist in
the body, acting upon some precursor, also known. The most logical choice for
the precursor is, of course, tyrosine, because simple introduction of a phenolic
hydroxyl group would yield dopa. One oxidizing system in the body is ascorbic
acid plus oxygen—and this system occurs notably in both the skin and the adrenal
glands (14, 15, 16). Coupled oxidation with ascorbic acid has been invoked to
account for a number of biological reactions. The relation of ascorbic acid and
skin pigment has been discussed by Cornbleet (17). The mechanism postulated
by Beyer (18) for introduction of second phenolic hydroxyl group is as follows:
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The over-all result in this particular case would be the reaction:
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Tyrosine Dihydroxyphenylalanine (Dopa)
EXPERIMENTAL
Twenty-five mg. of 1-tyrosine were dissolved in 35 ml. of M/15 phosphate
buffer at pH 7.0 together with 100 mg. of ascorbic acid and the solution aerated
for 70 mm. at 38.5°C. in a 50 ml. test tube by introducing air at the rate of one
small bubble per second. A 6 ml. aliquot was then removed to a centrifuge tube,
2 ml. of a suspension of aluminum added as an adsorbing agent, and the suspen-
sion made just basic to phenolphthalein by means of a few drops of 4N NaOH.
The aluminum hydroxide had been prepared according to Richter (19). After
being shaken, the tube was centrifuged and the supernatant liquid discarded.
Three-tenths ml. of a 25 per cent solution of sodium dihydrogen-phosphate and 2
ml. water were then added, the tube shaken to elute the dopa off the solid parti-
cles, and then centrifuged again. Approximately 0.06 ml. of the supernatant
liquid was applied to a strip of Whatman 1 filter paper and a paper chromato-
gram was prepared in a mamier similar to that of Consden, Gordon and Martin
(20).
The principle of paper chromatography is simply that a mixture of compounds,
especially amino acids, may be separated along the length of a narrow long strip
of paper and detected by various sensitive color reactions. The position of any
colored band thus developed is characteristic for a given compound, since it de-
pends upon the partition coefficient for this compound between the phase of
solvent (in this case phenol) saturated with water and the phase of cellulose
saturated with water. The terminology introduced by Consden, Gordon and
Martin for the position of the band is "R1," which denotes the ratio of the dis-
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tance which the given compound has traveled by the solvent. The use of various
solvents and proper choice of a color reaction may further increase the specificity.
The equipment is extremely simple, (fig. 1) but precautions are necessary to ob-
tain good results.
Strips were run in an inert atmosphere because if run in air no dopa could be
found on control tests. Nitrous oxide was chosen for the inert gas because it is
heavy and displaces air in the experimental jar by being run in from the top.
Fm. 2
Runs were made at 24—25°C. using 90 per cent phenol as the solvent. Colored
bands were developed with 0.1 per cent ninhydrin (triketohydrindene hydrate)
in butanol by immersing the strip briefly, and then drying and heating at 110°C.
for 10 minutes.
RESULTS
A definite purplish-pink band was found having an Rf value of 0.38. This
agrees with the value of 0.38 found in control runs under the same conditions
with known preparations of 1-dopa (fig. 2). A supporting test upon the solution
from the second centrifugation is given by the transient rose-red color developed
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after iodine and potassium iodide (Richter's test). This latter reaction is said to
be specific for the catechol nucleus and an ethylamine or isopropylamine side-
chain; however, it works well with 1-dopa, the color fading rapidly.
DISCUSSION
The Rf value found on the paper chromatogram makes it practically certain,
as explained above, that dopa is the compound producing the colored bands.
This, together with the positive Richter's test, leaves little doubt that ascorbic
acid and oxygen can cause the formation of dopa from tyrosine. Little can be
said about the quantities produced except for a rough estimate based upon the
depth of color in the colorimetric tests and chromatograms. From these it was
estimated that some 3 to 4 per cent of the tyrosine was converted under the con-
ditions described. The fact that the skin and adrenal glands both contain rela-
tively large amounts of ascorbic acid makes this mode of formation of dopa appear
feasible in the animal body.
SUMMARY
Dihydroxyphenylalanine was formed in vitro by the action of ascorbic acid and
oxygen upon 1-tyrosine. Its identity was established by paper chromatography.
The synthesis of dopa in vivo by this mechanism appears feasible, but has yet to
he established.
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DISCUSSION
Dr. Stephen Rothman: The presenters are to be Congratulated 011 the ingenious
application of their method and the successful isolation of dopa from tyrosine.
Recent studies indicate that mammalian epidermis does contain a partially
inhibited tyrosinase. In this year's Federation Proceedings, Fitzpatrick et al
reported that in the presence of traces of dopa the oxidation of tyrosine is enor-
mously accelerated.
Concerning the nature of inhibitory substances in human epidermis, data are
accumulating that these are sulfhydryl compounds. I wonder if the concentra-
tion of ascorbic acid used by Drs. Van Arman and Jones can be regarded as
physiological. The ascorbic acid content of the human epidermis seem to be
extremely low.
It has been known for a long time that ascorbic acid inhibits melanin formation
in the quinone stage. This is the reason that in the presence of ascorbic acid dopa
accumulates when tyrosine is being oxidized (J. Invest. Dermat. Vol. 3, No. 2).
Dr. Theodore Gornbleet: The method exhibited is an aerobic one; whereas, that
in vivo is probably anaerobic. Nevertheless, all the evidence points up the sig-
nificance of the reaction described by the essayists in the formation of melanin.
We have found ascorbic acid constantly present with pigment. Figge has shown
that the redox potential of ascorbic acid is optimum for tyrosinase activity.
Roper's classical scheme for the formation of pigment from tyrosine oxidizes the
latter as a first step to dihydroxyphenylalanine. On the other hand, according
to Lea's work the presence of ascorbic acid inhibits the enzymic oxidation of tyro-
sine. The clinical evidence in Addison's disease supports the latter view. We
have shown that the administration of vitamin C materially reduces the urinary
pigmentary substances in patients with malignant melanoma.
Rothman has postulated the presence of sulfhydryl substances in the skin that
inhibit melanogenesis. It seems to me that there is much to be said for this
view, except that I believe that ascorbic acid instead of sulfhydryl substances is
the inhibitor. As previously said, the presence of ascorbic acid inhibits the
enzymic oxidation of tyrosine. Sunlight, heat and other agents can oxidize or
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otherwise dispose of the blocking agent, vitamin C, whereupon, the enzymic re-
action remains free to proceed to the final production of melanin.
Maurice Oppenheim, M.D.: In 1902, 46 years ago, I published a preliminary
report from the University Clinic, Professor Neumann in Vienna, under the title,
"To The Question of Pigment Formation Out of Tyrosine." I followed a publi-
cation of my friend von Furth, Professor of Physiological Chemistry at the Uni-
versity of Vienna, who found that certain mushrooms like russula turn blue and
black after being exposed to the air. He concluded that under the influence of
tyrosinases the tyrosine forms melanin, and he found such conditions in animals
too. I concluded after certain experiments I made that the human epidermis
contains tyrosine, which under influence of oxydases form pigment. I could not
continue my experiments because my teacher Professor Ehrmann was convinced
that the melanin is a product of hemoglobin and that no other source of pigment
exists in the human skin. I would like to add that the pictures that Dr. Zimmer-
man has shown us, in the development of pigmentation in the Negro fetus are
almost identical to the pictures that Ehrmann published of the skin in Tritone
and Salamander embryos. I appreciate the excellent paper of Van Arman
and co-workers and the other discussers. This is only a brief historic remark on
this subject.
Mr. C. G. Van Arnian: I am sorry that we do not recall the paper in the Federa-
tion Proceedings cited by Dr. Rothman. However, we have known that tyrosin-
ase (and/or dopa oxidase, if they are different) is found in skin and in melanotic
tumors. We did not mean to say that the enzyme had not been demonstrated,
but only that dopa itself—the diphenolic compound—had not been proved
beyond all question. Of course the presence of the enzyme does very strongly
imply, almost proves, the presence of dopa.
The question whether our experimental conditions can be considered physio-
logical is difficult. The pH was 7.0. The concentration of ascorbic acid was
approximately 2 milligrams per milliliter, which is considerably greater than that
found in the skin, but not much greater than that in the fascicular layer of the
adrenal cortex.
We agree with Dr. Cornbleet's comments that the oxidation-reduction poten-
tial of a substance seems related to its ability to introduce a second hydroxyl
group. This seems quite in line with what we have read in the literature. Ap-
parently a low potential is necessary for a compound to function in coupled oxida-
tions. Sulfhydryl groups of course do have such a potential.
Dr. K. K. Jones: The formation of dihydroxyphenylalanine in the body is
assumed as a step in the formation of melanin. It is difficult to demonstrate a
way in which it may be formed that is physiological. Most of the methods by
which it is formed from tyrosine or phenylalanine are not compatible with cell life.
The formation by ascorbic acid oxidation is physiological in that it uses com-
pounds present in the cell and occurs at pH levels and redox potentials found in
living tissue.
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There is however a peculiar condition in that a strong reducing agent facilitates
oxidation. The explanation is that the energy of the oxygen atom does the
oxidizing. The energy of the oxygen molecule is about 117,000 calories. Ascor-
bic acid by accepting one atom of the molecule makes it posible for the other
atom to attack the benzene or phenyl ring and therefore insert the one or two
hydroxyl groups necessary to form dopa.
Ascorbic acid does not block the tyrosinase enzyme action. It prevents further
oxidation of the end products of enzyme action such as dopa quinone. The
mechanism is yet to be explained.
